November 30, 2016 - By Winifred Garcia · 0 Comments
Align Technology Inc (NASDAQ:ALGN) institutional sentiment increased to 1.41 in Q2 2016. Its up 0.16, from 1.25 in 2016Q1. The ratio has improved, as 165 funds increased or opened new holdings, while 132 sold and reduced their stock positions in Align Technology Inc. The funds in our partner’s database now own: 64.99 million shares, down from 67.84 million shares in 2016Q1. Also, the number of funds holding Align Technology Inc in their top 10 holdings decreased from 7 to 6 for a decrease of 1. Sold All: 33 Reduced: 99 Increased: 103 New Position: 62.
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing digital services used in dentistry, orthodontics and dental records storage. The company has a market cap of $7.49 billion. The Firm operates through two divisions: Clear Aligner segment and Scanner and Services (Scanner) segment. It has a 39.96 P/E ratio. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Express/Lite, Teen, Assist and Vivera Retainers, along with its training and ancillary products for treating malocclusion.
About 110,176 shares traded hands. Align Technology, Inc. (NASDAQ:ALGN) has risen 27.72% since April 27, 2016 and is uptrending. It has outperformed by 22.49% the S&P500.
Analysts await Align Technology, Inc. (NASDAQ:ALGN) to report earnings on January, 26. They expect $0.67 earnings per share, up 11.67% or $0.07 from last year’s $0.6 per share. ALGN’s profit will be $53.46 million for 34.98 P/E if the $0.67 EPS becomes a reality. After $0.63 actual earnings per share reported by Align Technology, Inc. for the previous quarter, Wall Street now forecasts 6.35% EPS growth.
According to Zacks Investment Research, “Align Technology Inc. designs, manufactures and markets the Invisalign System, a proprietary method for treating malocclusion. The System corrects malocclusion using a series of clear, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, the System significantly reduces the aesthetic and other limitations associated with braces. The Invisalign System also offers orthodontists a new means of carrying out their diagnosis and treatment planning processes.”
March Altus Capital Management Lp holds 10.78% of its portfolio in Align Technology, Inc. for 17,319 shares. Goodman Financial Corp owns 79,829 shares or 3.84% of their US portfolio. Moreover, Magee Thomson Investment Partners Llc has 3.7% invested in the company for 131,450 shares. The Pennsylvania-based Conestoga Capital Advisors Llc has invested 2.38% in the stock. Quantum Capital Management, a California-based fund reported 203,669 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 0 buys, and 9 sales for $14.03 million net activity.
Ratings analysis reveals 88% of Align Technology’s analysts are positive. Out of 8 Wall Street analysts rating Align Technology, 7 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $72 while the high is $110. The stock’s average target of $82.29 is -12.26% below today’s ($93.79) share price. ALGN was included in 15 notes of analysts from July 27, 2015. The stock of Align Technology, Inc. (NASDAQ:ALGN) earned “Overweight” rating by Piper Jaffray on Wednesday, November 18. Roth Capital maintained Align Technology, Inc. (NASDAQ:ALGN) rating on Wednesday, March 23. Roth Capital has “Buy” rating and $80 price target. As per Monday, October 3, the company rating was downgraded by Robert W. Baird. The stock of Align Technology, Inc. (NASDAQ:ALGN) earned “Buy” rating by Stifel Nicolaus on Monday, November 28. The stock of Align Technology, Inc. (NASDAQ:ALGN) has “Buy” rating given on Friday, October 23 by Stifel Nicolaus. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, January 29. The stock of Align Technology, Inc. (NASDAQ:ALGN) has “Outperform” rating given on Wednesday, May 11 by Credit Suisse. Leerink Swann initiated the shares of ALGN in a report on Friday, September 11 with “Outperform” rating.
Align Technology, Inc., incorporated on April 3, 1997, designs, makes and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Firm operates through two divisions: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Express/Lite, Teen, Assist and Vivera Retainers, along with its training and ancillary products for treating malocclusion. The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Company’s iTero scanner is used by dental professionals, and labs and services for restorative and orthodontic digital procedures, as well as Invisalign digital impression submission.
More recent Align Technology, Inc. (NASDAQ:ALGN) news were published by: Fool.com which released: “Align Technology Inc. Beats Q3 Expectations With Record Invisalign Volume” on November 07, 2016. Also Streetinsider.com published the news titled: “Form 4 ALIGN TECHNOLOGY INC For: Nov 29 Filed by: Olson Jennifer” on November 30, 2016. Nasdaq.com‘s news article titled: “Earnings Reaction History: Align Technology, Inc., 71.4% Follow-Through …” with publication date: November 07, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Winifred Garcia